Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do beta-adrenergic blocking agents increase coronary flow reserve?

M Billinger1, C Seiler, M Fleisch

  • 1Department of Cardiology, Swiss Cardiovascular Center, Bern, Switzerland.

Journal of the American College of Cardiology
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When conditioned responses "fire back": bidirectional cross-activation creates learning opportunities in synesthesia.

Neuroscience·2007
Same author

Cytokine activation and disease progression in patients with stable moderate chronic heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2007
Same author

Sex differences in semantic processing: event-related brain potentials distinguish between lower and higher order semantic analysis during word reading.

Cerebral cortex (New York, N.Y. : 1991)·2006
Same author

The effect of genotype and cultivation method on the total salicylate yield of dark-leaved willows (Salix myrsinifolia).

Planta medica·2006
Same author

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Heart (British Cardiac Society)·2005
Same author

Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy.

Heart (British Cardiac Society)·2005
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Metoprolol significantly improves coronary flow velocity reserve (CFVR) in patients with coronary artery disease (CAD) by reducing vascular resistance. This beta-blocker enhances blood supply and reduces oxygen demand, benefiting CAD treatment.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Physiology

Background:

  • Beta-adrenergic blocking agents are crucial for treating coronary artery disease (CAD).
  • The precise mechanism of action, particularly regarding oxygen-sparing effects, requires further elucidation.
  • This study investigates metoprolol's impact on coronary flow reserve and coronary flow velocity reserve (CFVR) in CAD patients.

Purpose of the Study:

  • To determine the effect of metoprolol on coronary flow reserve and coronary flow velocity reserve (CFVR) in patients with CAD.
  • To assess changes in coronary blood flow velocity, post-ischemic CFVR, and pharmacologic CFVR before and after metoprolol administration.
  • To evaluate the impact of metoprolol on coronary vascular resistance and its relationship with CFVR.

Main Methods:

Related Experiment Videos

  • Coronary blood flow velocity was measured using a Doppler flow wire in 23 CAD patients.
  • Measurements included rest, post-ischemic (1-min occlusion), and post-adenosine (pharmacologic) conditions.
  • Changes were assessed before and after administering 5 mg of intravenous metoprolol, with absolute flow measured in a subgroup.

Main Results:

  • Metoprolol reduced the rate-pressure product (9.1 to 8.0 x 10(3) mm Hg/min) and coronary vascular resistance (3.4 to 2.3 mm Hg x s/cm).
  • Both pharmacologic CFVR (2.1 to 2.7) and post-ischemic CFVR (2.6 to 3.3) significantly increased post-metoprolol.
  • Post-ischemic CFVR remained significantly higher than pharmacologic CFVR, both before and after metoprolol treatment.

Conclusions:

  • Metoprolol administration leads to a significant increase in both post-ischemic and pharmacologic CFVR in CAD patients.
  • The observed increase in CFVR is attributed to a reduction in coronary vascular resistance.
  • The combined effects of increased coronary blood supply (via CFVR) and decreased myocardial oxygen demand explain metoprolol's therapeutic benefits in CAD.